tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Butler, 237 are a BUY (95.56%), 10 are a HOLD (4.03%), 1 are a SELL (0.4%).
Analyst Jason Butler, currently employed at JMP, carries an average stock price target met ratio of 36.34% that have a potential upside of 43.94% achieved within 176 days.
Jason Butler’s has documented 468 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on CYTK, Cytokinetics at 10-Apr-2025.
Analyst best performing recommendations are on TRVN (TREVENA).
The best stock recommendation documented was for HALO (HALOZYME THERAPEUTICS) at 2/24/2021. The price target of $48 was fulfilled within 1 day with a profit of $3.45 (6.71%) receiving and performance score of 67.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$28
$13.27 (90.09%)
$28
16 days ago
(08-Apr-2025)
0/7 (0%)
$13.9 (98.58%)
Hold
$20
$5.27 (35.78%)
$20
1 months 17 days ago
(07-Mar-2025)
16/21 (76.19%)
$2.39 (13.57%)
172
Buy
$27
$12.27 (83.30%)
$27
1 months 28 days ago
(27-Feb-2025)
7/21 (33.33%)
$7.66 (39.61%)
118
Buy
$28
$13.27 (90.09%)
$28
1 months 28 days ago
(27-Feb-2025)
25/37 (67.57%)
$8.66 (44.78%)
486
Hold
$22
$7.27 (49.36%)
$24
2 months 13 days ago
(11-Feb-2025)
16/21 (76.19%)
$3.51 (18.98%)
174
Which stock is Jason Butler is most bullish on?
Which stock is Jason Butler is most reserved on?
What Year was the first public recommendation made by Jason Butler?
